Methadone and Oral Health – A Brief Review

References

1. 1. Brondani MA,
   2. Clark C,
   3. Rossoff L,
   4. Aleksejuniene J

   . An Evolving Community-Based Dental Course on Professionalism and Community Service. J Dent Educ. 2008;72(10):1160–1168.

   OpenUrlAbstract/FREE Full Text
2. 1. Titsas A,
   2. Ferguson MM

   . Impact of Opioid use on Dentistry. Aust Dent J. 2002;47(2):94–98.

   OpenUrlCrossRefPubMed
3. 1. Farnsworth N

   . Oral Health Project for people on Methadone programs & with substance use issues in the Outer Eastern Metropolitan Region. Department of Health [Internet]. 2004 [cited 2009 Jan 23]. Available from: www.health.vic.gov.au/healthpromotion/downloads/fr_knox.pdf
4. 1. Olds K

   . Mass evictions in Vancouver: the human toll of Expo ’86. Can Housing 1989;6:49–53.

   OpenUrl
5. 1. Farnsworth N

   . Oral Health Project for people on Methadone programs & with substance use issues in the Outer Eastern Metropolitan Region 2004. Available at www.health.vic.gov.au/healthpromotion/downloads/fr_knox.pdf [Retrieved 12 Jan 2009]
6. 1. Bigwood CS,
   2. Coelho AJ

   . Methadone and Caries. Br Dent J. 1990;168(6):231.

   OpenUrlPubMed
7. 1. Birnbaum W

   . Public dental health: Dental health access - are drug users encouraged to use our services? Br Dental J. 2001;191:446.

   OpenUrl
8. 1. Carr KD,
   2. Papadouka V

   . The role of multiple opioid receptors in the potentiating of reward by food restriction. Brain Res. 1994;639(2):253–260.

   OpenUrlCrossRefPubMed
9. 1. Charnock S,
   2. Owen S,
   3. Brookes V,
   4. Williams M

   . A community based programme to improve access to dental services for drug users. Br Dent J. 2004;196(7):385–388.

   OpenUrlPubMed
10. 1. Colon PG Jr.

    . Dental disease in the narcotic addict. Oral Surg Oral Med Oral Pathol. 1972;33(6):905–910.

    OpenUrlPubMed
11. 1. Götrick B,
    2. Akerman S,
    3. Ericson D,
    4. Torstenson R,
    5. Tobin G

    . Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res. 2004;83(5):393–397.

    OpenUrlAbstract/FREE Full Text
12. 1. Hutchinson S

    . Methadone and Caries. Br Dent J. 1990;168(11):430.

    OpenUrlPubMed
13. 1. Lewis DA

    . Methadone and Caries. Br Dent J. 1990;168(9):349.

    OpenUrlPubMed
14. 1. Mao J,
    2. Sung B,
    3. Ji RR,
    4. Lim G

    . Neuronal apoptosis associated with morphine tolerance for an opioid-induced neurotoxic mechanism. J Neurosci. 2002;22(17):7650–7661.

    OpenUrlAbstract/FREE Full Text
15. 1. Meaney PJ

    . Methadone and Caries. Aust Dent J. 1997;42(2):138.

    OpenUrlPubMed
16. 1. Mercadante S,
    2. Calderone L,
    3. Villari P,
    4. et al

    . The use of pilocarpine in opioid-induced xerostomia. J Palliat Med. 2000;14(6):529–531.

    OpenUrl
17. 1. Molendijk B,
    2. Ter Horst G,
    3. Kasbergen M,
    4. Truin GJ,
    5. Mulder J

    . Dental Health in Dutch drug addicts. Community Dent Oral Epidemiol. 1996;24(2):117–119.

    OpenUrlPubMed
18. 1. Nathwani NS,
    2. Gallagher JE

    . Methadone: dental risks and preventive action. Dent Update. 2008;35(8):542-544, 547-548.
19. 1. Alonzo NC,
    2. Bayer BM

    . Opioids, immunology, and host defenses of intravenous drug abusers. Infect Dis Clinics North Am. 2002;16(3):553–569.

    OpenUrlCrossRefPubMed
20. 1. Reece AS

    . Dentition of addiction in Queensland: poor dental status and major contributing drugs. Aust Dent J. 2007;52(2):144–149.

    OpenUrlCrossRefPubMedWeb of Science
21. 1. Robinson PG,
    2. Acquah S,
    3. Gibson B

    . Drug users: Oral health related attitudes and behaviours. Br Dent J. 2005;198(4):219–224.

    OpenUrlCrossRefPubMed
22. 1. Rosenstein DI

    . Effect of long term addiction to heroin on oral tissues. J Public Health Dent. 1975;35(2):118–122.

    OpenUrlPubMed
23. 1. Scheutz F

    . Anxiety and dental fear in a group of parenteral drug addicts. Scand J Dent Res. 1986;94(3):241–247.

    OpenUrlPubMed
24. 1. Sheedy JJ

    . Methadone and Caries. Case reports. Aust Dent J. 1996;41(6):367–369.

    OpenUrlCrossRefPubMed
25. 1. Sheridan J,
    2. Aggleton M,
    3. Carson T

    . Dental health and access to dental treatment: a comparison of drug users and non-drug users attending community pharmacies. Br Dent J. 2001;191(8):453–457.

    OpenUrlCrossRefPubMed
26. 1. Sheridan J,
    2. Carson T,
    3. Aggleton M

    . Providing dental health services to drug users: testing a model for a community pharmacy advice and referral scheme. Pharmaceutical J. 2003;271:180–182.

    OpenUrl
27. 1. Szabo I,
    2. Rojavin M,
    3. Bussiere JL,
    4. Eisenstein TK,
    5. Adler MW,
    6. Rogers TJ

    . Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther. 1993;267(2):703–706.

    OpenUrlAbstract/FREE Full Text
28. 1. Toombs JD,
    2. Kral LA

    . Methadone Treatment for Pain States. Am Fam Physician. 2005;71(7):1353–1358.

    OpenUrlPubMedWeb of Science
29. 1. Tramullas M,
    2. Martínez-Cué C,
    3. Hurlé MA

    . Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. Psychopharmacology (Berl). 2007;193(1):107–120.

    OpenUrlCrossRefPubMed
30. 1. Vallejo R,
    2. de Leon-Casasola O,
    3. Benyamin R

    . Opioid Therapy and Immunosuppression - a review. Am J Ther. 2004;11(5):354–365.

    OpenUrlCrossRefPubMed
31. 1. Winocur E,
    2. Gavish A,
    3. Volfin G,
    4. Halachmi M,
    5. Gazit E

    . Oral motor parafunctions among heavy drug addicts and their effects on signs and symptoms of temporomandibular disorders. J Orofacial Pain. 2001;15(1):56–63.

    OpenUrlPubMed
32. 1. Zador D,
    2. Lyons Wall PM,
    3. Webster I

    . High sugar intake in a group of women on methadone maintenance in South Western Sydney, Australia. Addiction. 1996;91(7):1053–1061.

    OpenUrlCrossRefPubMedWeb of Science
33. Status Report 2008. NAOMI [Internet]. [cited 2008 October 30]. Available from: http://www.naomistudy.ca/pdfs/NAOMI_Update_October_2008%20.pdf
34. 1. Krantz MJ,
    2. Mehler PS

    . Treating Opioid Dependence: Growing Implications for Primary Care. Arch Intern Med. 2004;164(3):277–288.

    OpenUrlCrossRefPubMedWeb of Science
35. 1. Fiellin DA,
    2. O’Connor PG

    . Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347(11):817–823.

    OpenUrlCrossRefPubMedWeb of Science
36. 1. Scheutz F

    . Dental health is a group of drug addicts attending an addiction-clinic. Community Dent Oral Epidemiol. 1984;12(1):23–28.

    OpenUrlCrossRefPubMedWeb of Science
37. 1. Sacerdote P,
    2. Franchi S,
    3. Gerra G,
    4. Leccese V,
    5. Panerai AE,
    6. Somaini L

    . Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav Immun. 2008;22(4):606–613.

    OpenUrlCrossRefPubMed
38. 1. Neri S,
    2. Bruno CM,
    3. Pulvirenti D,
    4. et al

    . Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl). 2005;179(3):700–704.

    OpenUrlPubMed
39. 1. Alonzo NC,
    2. Bayer BM

    . Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine. J Pharmacol Exp Ther. 2003;307(2):793–800.

    OpenUrlAbstract/FREE Full Text
40. 1. Shaner JW

    . Caries associated with methamphetamines abuse. J Mich Dent Assoc. 2002;84(9):42–47.

    OpenUrlPubMed
41. 1. Klasser GD,
    2. Epstein J

    . Methamphetamine and its impact on dental care. J Can Dent Assoc. 2005;71(10):759–762.

    OpenUrlPubMed